Mini Samples ELISA Kit for Cancerous Inhibitor Of PP2A (CIP2A)

p90; KIAA1524

Specificity

This assay has high sensitivity and excellent specificity for detection of Mini Samples Cancerous Inhibitor Of PP2A (CIP2A).
No significant cross-reactivity or interference between Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-95 89
EDTA plasma(n=5) 97-104 101
heparin plasma(n=5) 90-101 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Cancerous Inhibitor Of PP2A (CIP2A) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-104% 81-102% 85-103% 80-99%
EDTA plasma(n=5) 78-101% 81-105% 78-97% 93-101%
heparin plasma(n=5) 81-95% 98-105% 84-93% 98-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×60µL Assay Diluent A 1×6mL
Detection Reagent B 1×60µL Assay Diluent B 1×6mL
TMB Substrate 1×4.5mL Stop Solution 1×3mL
Wash Buffer (30 × concentrate) 1×10mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPR982Hu01 Recombinant Cancerous Inhibitor Of PP2A (CIP2A) Positive Control; Immunogen; SDS-PAGE; WB.
PAR982Hu01 Polyclonal Antibody to Cancerous Inhibitor Of PP2A (CIP2A) WB; IHC; ICC; IP.
MAR982Hu21 Monoclonal Antibody to Cancerous Inhibitor Of PP2A (CIP2A) WB; IHC; ICC; IP.
MER982Hu Mini Samples ELISA Kit for Cancerous Inhibitor Of PP2A (CIP2A) Enzyme-linked immunosorbent assay for Antigen Detection.
SER982Hu ELISA Kit for Cancerous Inhibitor Of PP2A (CIP2A) Enzyme-linked immunosorbent assay for Antigen Detection.